Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients
Clinical trial NCT02314637 · COMPLETED
Trial details
- NCT number
- NCT02314637
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-07-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.